secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMYRIS, INC. (—)
CIK:        0001365916
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001365916-23-000151
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amyris sells Biossance brand for $20M, cuts 220 jobs; Nov net loss $36.7M
-------------------------------------------------------------------------

- Sold Biossance brand assets to THG Beauty USA LLC for $20M; Bankruptcy Court approved Dec 12, closed Dec 28.
- Terminated approx 220 employees Dec-Jan 2024; combined RIFs reduce workforce ~51% from June 2023.
- Expects $2.4M one-time charge in Q4 2023/Q1 2024 for severance and benefits.
- Nov 2023 MOR: net loss $36.7M, cumulative net loss $167.4M, cash $17.6M, total liabilities $1.30B.
- Prepetition unsecured debt $738.7M, equity deficit $489.3M; postpetition payables $175.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/0001365916-23-000151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/amrs-20231228.htm
  HTML page:      https://secwatch.observer/filing/0001365916-23-000151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer